Product Program year 2020 Source: CMS Open Payments

VantageView System

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$4,915

81 payments

Research payments

$0

0 payments

Through program year 2020, $4,915 in general payments and $0 in research payments were reported against VantageView System (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $2,729 42
2019 General $2,186 39

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $4,915 81 payments
Top recipients General payments · program year 2020
  1. Cyrus Hadadi Cardiovascular Disease · Norfolk, VA $1,347 49% · 7 payments
  2. Luis Rechani Clinical Cardiac Electrophysiology · Naples, FL $165 6% · 1 payment
  3. Dale Yoo Clinical Cardiac Electrophysiology · McKinney, TX $156 6% · 1 payment
  4. Daniel Friedman Clinical Cardiac Electrophysiology · Bradenton, FL $151 6% · 1 payment
  5. John Marenco Clinical Cardiac Electrophysiology · Springfield, MA $144 5% · 1 payment

The top 5 of 30 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $1,571 58% · 8 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $1,120 41% · 20 practitioners
  3. Interventional Cardiology Internal Medicine $22 <1% · 1 practitioner
  4. Ophthalmology $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. District of Columbia $1,347 49% · 1 recipient
  2. Texas $423 16% · 11 recipients
  3. Florida $402 15% · 7 recipients
  4. Massachusetts $287 11% · 2 recipients
  5. New Hampshire $97 4% · 2 recipients

The top 5 of 9 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

81 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record